Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 9, 2007, Pages 1828-1832

  Mucci, Lorelei A ^a,b   Dickman, Paul W ^c   Lambe, Mats ^c   Adami, Hans Olov ^b,c   Trichopoulos, Dimitrios ^b,d   Riman, Tomas ^e,f   Hsieh, Chung Cheng ^b,g   Cnattingius, Sven ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e FALUN HOSPITAL   (Sweden)

^f Center for Clinical Research   (Sweden)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIRTH WEIGHT; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CONTROLLED STUDY; FEMALE; FETUS GROWTH; FOLLOW UP; GESTATIONAL AGE; HAZARD RATIO; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; OVARY CANCER; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; HUMANS; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 34548860353     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0962     Document Type: Article

References (42)

1. Adami HO, Hsieh CC, Lambe M, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994;344:1250-4.
2. Hankinson SE, Colditz GA, Hunter DJ, et al. A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 1995;76:284-90.
3. Modan B, Hartge P, Hirsh-Yechezkel G, et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:235-40.
4. Liu Q, Lambe M, Baik I, et al. A prospective study of the transient decrease in ovarian cancer following childbirth. Cancer Epidemiol Biomarkers Prev 2006;15:2508-13.
5. Gertig D, Hunter D. Ovarian Cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology: Oxford University Press; 2002.
6. Goodwin TM. A role for estriol in human labor, term and preterm. Am J Obstet Gynecol 1999;180:S208-13.
7. Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A. Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology 2000;11:315-9.
8. Peck JD, Hulka BS, Savitz DA, Baird D, Poole C, Richardson BE. Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol 2003;157:258-66.
9. Mucci LA, Lagiou P, Tamimi RM, Hsieh CC, Adami HO, Trichopoulos D. Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control 2003;14:311-8.
10. Fisher DA. The unique endocrine milieu of the fetus. J Clin Invest 1986;78:603-11.
11. Mogren I, Stenlund H, Hogberg U. Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 2001;40:849-54.
12. Olsen J, Storm H. Pregnancy experience in women who later developed oestrogen-related cancers (Denmark). Cancer Causes Control 1998;9:653-7.
13. The Swedish Medical Birth Register: A Summary of Content and Quality. Stockholm: Centre for Epidemiology, The National Board of Health and Welfare; 2003. Report no. 2003-112-3.
14. Cancer Incidence in Sweden 2004. Stockholm: Centre for Epidemiology, The National Board of Health and Welfare, Sweden; 2005. Report no. 2005-42-9.
15. Causes of Death 2003. Stockholm:Centre for Epidemiology, The National Board of Health and Welfare, Sweden; 2005. Report no. 2006-42-3.
16. Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 2005;96:520-30.
17. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86.
18. Munstedt K, Steen J, Knauf AG, Buch T, von Georgi R, Franke FE. Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 2000;89:1783-91.
19. Riman T, Dickman PW, Nilsson S, et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002;94:497-504.
20. Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 2001;84:714-21.
21. Lambe M, Wuu J, Rossing MA, Hsieh CC. Twinning and maternal risk of ovarian cancer. Lancet 1999;353:1941.
22. Whiteman DC, Murphy MF, Cook LS, et al. Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst 2000;92:1172-7.
23. La Vecchia C, Negri E, Talamini R, Conti E, Montella M, Franceschi S. Re: Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst 2001;93:319-20.
24. Dionne CE, Soderstrom M, Schwartz SM. Seasonal variation of twin births in Washington State. Acta Genet Med Gemellol (Roma) 1993;42:141-9.
25. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 2006;47:203-8.
26. Laviola L, Perrini S, Belsanti G, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 2005;146:1498-505.
27. Holmes RP, Holly JM, Soothill PW. A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses. Br J Obstet Gynaecol 1998;105:1273-8.
28. Druckmann R, Rohr UD. IGF-1 in gynaecology and obstetrics: update 2002. Maturitas 2002;41 Suppl 1:S65-83.
29. Gohlke BC, Huber A, Bartmann P, et al. Cord blood leptin and IGF-I in relation to birth weight differences and head circumference in monozygotic twins. J Pediatr Endocrinol Metab 2006;19:3-9.
30. Lukanova A, Lundin E, Toniolo P, et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002;101:549-54.
31. Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 2001;83:575-85.
32. Filicori M, Cognigni GE, Gamberini E, Troilo E, Parmegiani L, Bernardi S. Impact of medically assisted fertility on preterm birth. BJOG 2005;112 Suppl 1:113-7.
33. McGovern PG, Llorens AJ, Skurnick JH, Weiss G, Goldsmith LT. Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis. Fertil Steril 2004;82:1514-20.
34. Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR. Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 2005;20:200-8.
35. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554-9.
36. Thatcher SS, Jackson EM. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 2006;85:1002-9.
37. Weerakiet S, Srisombut C, Rojanasakul A, Panburana P, Thakkinstian A, Herabutya Y. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2004;19:134-40.
38. Sir-Petermann T, Hitchsfeld C, Maliqueo M, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005;20:2122-6.
39. Linne Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 2004;5:137-43.
40. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999;23:617-35.
41. Cnattingius S, Ericson A, Gunnarskog J, Kallen B. A quality study of a medical birth registry. Scand J Soc Med 1990;18:143-8.
42. Mucci LA, Lagiou P, Hsieh CC, et al. A prospective study of pregravid oral contraceptive use in relation to fetal growth. BJOG 2004;111:989-95.